Cytostatic and phagocytic capacity of lymphokine-activated human monocytes. 1979

G Unsgaard

Human monocytes were rendered cytostatic to the human cell line NHIK 3025 by exposure to lymphokine supernatants (LS) from BCG-stimulated lymphocytes. Exposure to LS for 1, 2 and 4 h induced a considerable cytostatic capacity in the monocytes. However, a stronger cytostatic effect was acquired by exposure to LS for 24 h and 72 h. The phagocytosis of 125I-labelled Candida albicans by LS-activated monocytes was compared with phagocytosis by monocytes treated with control supernatants (CS). The ingestion was increased by short exposure to LS. However, a 72-h exposure to LS induced a decreased ingestion capacity. The capacity of the LS-activated monocytes to digest ingested C. albicans was suppressed. DNA synthesis was increased in the LS-activated monocytes, while protein synthesis was not significantly influenced. The cytostatic capacity of LS-activated monocytes was abolished by culture for 24 h after removal of LS. Following removal of LS or CS with subsequent culture for 4 days, morphological and functional signs of differentiation were less marked in the LS-treated than in the CS-treated cells. The survival was also reduced in the former cells. However, these cells were strongly reactivated by re-exposure to LS.

UI MeSH Term Description Entries
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D002176 Candida albicans A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis). Candida albicans var. stellatoidea,Candida stellatoidea,Dematium albicans,Monilia albicans,Myceloblastanon albicans,Mycotorula albicans,Parasaccharomyces albicans,Procandida albicans,Procandida stellatoidea,Saccharomyces albicans,Syringospora albicans
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA

Related Publications

G Unsgaard
January 1988, Cellular immunology,
G Unsgaard
December 1981, Acta pathologica et microbiologica Scandinavica. Section C, Immunology,
G Unsgaard
January 1989, Cancer immunology, immunotherapy : CII,
G Unsgaard
January 1987, Journal of pediatric gastroenterology and nutrition,
G Unsgaard
December 1988, Journal of immunology (Baltimore, Md. : 1950),
G Unsgaard
January 1974, The Journal of clinical investigation,
G Unsgaard
January 1991, Cancer detection and prevention,
G Unsgaard
August 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Copied contents to your clipboard!